from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A human monoclonal antibody intended to treat invasive Candida infection in combination with amphotericin B.


from Wiktionary, Creative Commons Attribution/Share-Alike License

-fung- +‎ -u- +‎ -mab


Help support Wordnik (and make this page ad-free) by adopting the word efungumab.


  • Mycograb (efungumab) as an add-on therapy to treat invasive candidiasis in adults has resulted in a write off of $360m, to be taken in

    Novartis Reveals the High Cost of Failure -- Seeking Alpha 2010

  • This last entry is perhaps the most significant as Novartis also have several hsp90 inhibitors in clinical development, most notably Mycograb (efungumab), which is in final stage trials for fungal infections and also in earlier stage trials for cancer.

    DrugResearcher RSS 2009


Log in or sign up to get involved in the conversation. It's quick and easy.